Achiko AG, established in 2018 and based in Zurich, Switzerland, focuses on... Achiko AG, established in 2018 and based in Zurich, Switzerland, focuses on pioneering diagnostic technologies for both Indonesian and international markets. Its flagship innovation is AptameX, a rapid diagnostic test that identifies the SARS-CoV-2 virus by utilizing DNA aptamers, distinguishing it from traditional antigen-based methods. The company also offers Teman Sehat, a mobile application serving as a check-in and digital health passport. Additionally, under the Mimopay brand, Achiko AG provides secure payment processing, enabling game publishers and application developers to accept diverse payment methods for digital content and merchandise. The firm is also involved in the development of game software.
